Virology, Immunology, Immunity, Vaccinia and Vaccination are his primary areas of study. His Virology study incorporates themes from Viral vector and CD8, Immune system, Antigen. His research links Heterologous with Immunology.
The concepts of his Immunity study are interwoven with issues in Plasmodium falciparum and Antibody. The various areas that Stefano Colloca examines in his Vaccinia study include Virus and Immunization. His work carried out in the field of Vaccination brings together such families of science as Vector and Immunogenicity.
His scientific interests lie mostly in Virology, Immunology, Antigen, Vaccination and Viral vector. His Virology research incorporates elements of T cell, Immune system, Immunity and Immunogenicity. His studies deal with areas such as Vaccinia and Modified vaccinia Ankara as well as Immunology.
Stefano Colloca combines subjects such as Plasmodium falciparum, Heterologous and Cancer research with his study of Antigen. His Vaccination research is multidisciplinary, incorporating perspectives in Ebola vaccine, Neutralizing antibody and Ebolavirus. His study looks at the relationship between Viral vector and fields such as Adenoviridae, as well as how they intersect with chemical problems.
Stefano Colloca mainly investigates Virology, Vaccination, Antigen, T cell and Immunology. Stefano Colloca has researched Virology in several fields, including Immune system, Immunity, Immunogenicity, Viral vector and Epitope. His Immunogenicity research incorporates themes from Vector and Modified vaccinia Ankara.
His study in the fields of Chimpanzee adenovirus under the domain of Viral vector overlaps with other disciplines such as Laminin. His studies examine the connections between Vaccination and genetics, as well as such issues in Simian, with regards to Anti viral immunity and Clinical trial. Stefano Colloca interconnects Virus, Cancer research and Antibody in the investigation of issues within Antigen.
His primary areas of study are Virology, Immunology, Immunity, Vaccination and Immunogenicity. His Virology research is multidisciplinary, relying on both ELISPOT, Mucosal immunity and Immune system. His Mucosal immunity research incorporates elements of Viral vector and Chimpanzee adenovirus.
His studies deal with areas such as Viremia, Antigen and Modified vaccinia Ankara as well as Viral load. His Antigen study combines topics in areas such as Interferon and Hepatitis C virus. His Ebola virus research includes elements of Vaccinia and Antibody.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man
Eleanor Barnes;Eleanor Barnes;Antonella Folgori;Stefania Capone;Leo Swadling.
Science Translational Medicine (2012)
A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees.
Antonella Folgori;Stefania Capone;Lionello Ruggeri;Annalisa Meola.
Nature Medicine (2006)
Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge
Daphne A Stanley;Anna N Honko;Anna N Honko;Clement Asiedu;John C Trefry.
Nature Medicine (2014)
A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory.
Leo Swadling;Stefania Capone;Richard D. Antrobus;Anthony Brown.
Science Translational Medicine (2014)
Protective CD8 + T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation
Katie J Ewer;Geraldine A O'Hara;Christopher J A Duncan;Katharine A Collins.
Nature Communications (2013)
Chimpanzee Adenovirus Vector Ebola Vaccine
Julie E. Ledgerwood;Adam D. DeZure;Daphne A. Stanley;Emily E. Coates.
The New England Journal of Medicine (2017)
Vaccine Vectors Derived from a Large Collection of Simian Adenoviruses Induce Potent Cellular Immunity Across Multiple Species
Stefano Colloca;Eleanor Barnes;Antonella Folgori;Virginia Ammendola.
Science Translational Medicine (2012)
A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA
Katie Ewer;Tommy Rampling;Navin Venkatraman;Georgina Bowyer.
The New England Journal of Medicine (2016)
Clinical Assessment of a Recombinant Simian Adenovirus ChAd63: A Potent New Vaccine Vector
Geraldine A. O’Hara;Christopher J. A. Duncan;Katie J. Ewer;Katharine A. Collins.
The Journal of Infectious Diseases (2012)
Prime-boost vectored malaria vaccines: progress and prospects.
Adrian V S Hill;Arturo Reyes-Sandoval;Geraldine O'Hara;Katie Ewer.
Human Vaccines (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: